Table 2 Clinical characteristics of the study participants.
Variables | Category | Frequency | Percent |
|---|---|---|---|
CD4 T-cell count (cell/mm3) | < 500 | 233 | 56.1 |
≥ 500 | 182 | 43.9 | |
Viral load | Suppressed | 391 | 94.2 |
Non-suppressed | 24 | 5.8 | |
WHO clinical staging | WHO stage I | 332 | 80 |
WHO stage II | 83 | 20 | |
Duration of living with HIV | ≤ 10 years | 205 | 49.4 |
> 10 years | 210 | 50.6 | |
Duration of taking ART | ≤ 5 years | 182 | 43.9 |
> 5 years | 233 | 56.1 | |
Duration of taking DTG | ≤ 2 years | 175 | 42.2 |
> 2 years | 240 | 57.8 | |
History of OIs in the last 6 months | Yes | 33 | 8 |
No | 382 | 92 | |
Drug adherence level | Good | 355 | 85.5 |
Fair | 35 | 8.4 | |
Poor | 25 | 6 | |
Comorbidities | Yes | 45 | 10.8 |
No | 370 | 89.2 | |
Family history of hypertension | Yes | 47 | 11. 3 |
No | 368 | 88.7 | |
Family history of CVD | Yes | 26 | 6.3 |
No | 389 | 93.7 | |
Family history of DM | Yes | 44 | 10.6 |
No | 371 | 89.4 |
